Alt
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Nuclear Radiology_Headshot_GA_Dr Yong Du.jpg

Dr Yong Du

Dr Yong Du
Yong
Du
MBBS MSc PhD FRCP Nuclear medicine physician

Languages spoken

English

Expert in

Prostate cancer

Overview

Centres

Windsor
Windsor

69 Alma Road, Windsor, SL4 3HD

51.47755, -0.61809
/uk/our-centres/windsor
+44 (0)1753 418444
mediahawkNumber3686 mhMobile

Specialises in

Prostate cancer
Condition
Condition/Cancer
Condition/Cancer/Prostate cancer

Treatments

Blood tests
Service
Service/Cancer
Service/Cancer/Pathology tests and procedures
Service/Cancer/Pathology tests and procedures/Blood test
PET/CT scan
Service
Service/Cancer
Service/Cancer/Imaging scans
Service/Cancer/Imaging scans/PET CT
Theranostics
Service
Service/Cancer
Service/Cancer/Theranostics
Service/Cancer/Theranostics/Theranostics

Special clinical interest in PET/CT, SPECT/CT, Radionuclide Target Therapy

Dr Yong Du is a Consultant Physician in Nuclear Medicine & PET/CT. He completed Nuclear Medicine specialist training at the Institute of Nuclear Medicine in UCLH and obtained his PhD degree in radioummunotherapy for lymphoma. Dr Yong Du has extensive experience in both Diagnostic and Therapeutic Nuclear Medicine. He was the first recipient of the UK HEFCE Clinical Senior Lecturership award in the Nuclear Medicine specialty. He has been the Clinical Lead for radionuclide therapy services at the Royal Marsden Hospital, the biggest cancer centre in the UK since February 2011.

He has treated a large number of patients with thyrotoxicosis, thyroid cancer, lymphoma, neuroblastoma, neuroendocrine tumour and prostate cancer. Dr Yong Du was awarded the first clinical ARSAC licence in UK to treat prostate cancer patients with Lu-177-PSMA, in February 2018.

Career positions

Current position(s)

  • Consultant Physician in Nuclear Medicine & PET/CT
  • Clinical Lead for radionuclide therapy services at the Royal Marsden Hospital

Education

Universities

  • Institute of Nuclear Medicine in UCLH

Expertise and interests

Interests

  • Nuclear Medicine
  • PET/CT
  • SPECT/CT
  • Radionuclide Target Therapy

Professional associations

  • GMC
  • MPS
  • RCP
  • BNMS
  • EANM
  • Dr Yong Du is a Trustee of the British Nuclear Medicine Society and he is a committee member of a number of national and international professional bodies including NCRI CTRad and Radionuclide Target Therapy Committee of BNMS.

Accomplishments

Awards

  • HEFCE Clinical Senior lecturer (Awarded in June 2009)

Publications & affiliations

  • He has led a number of national and international research projects and has published first-authored research articles in high impact oncology journals including the Journal of Clinical Oncology, Blood, Cancer Research, EJNMMI, etc.